Cargando…
Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
OBJECTIVE: To estimate and compare the cost-effectiveness and safety of nebivolol with sustained-release metoprolol in reducing blood pressure by 1 mm of Hg per day in hypertensive patients. MATERIALS AND METHODS: This was a prospective, randomized, open label, observational analysis of cost-effecti...
Autores principales: | Patel, Rachna S., Sharma, Kamal H., Kamath, Nitisha A., Patel, Nirav H., Thakkar, Ankita M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4175882/ https://www.ncbi.nlm.nih.gov/pubmed/25298575 http://dx.doi.org/10.4103/0253-7613.140577 |
Ejemplares similares
-
Effects of Metoprolol and Nebivolol on Exercise Blood Pressure in Patients with Mild Hypertension
por: Yazici, Huseyin Ugur, et al.
Publicado: (2013) -
Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension
por: Soanker, Radhika, et al.
Publicado: (2012) -
Effects of nebivolol versus other antihypertensive drugs on the endothelial dysfunction in patients with essential hypertension
por: Li, Bingwei, et al.
Publicado: (2020) -
Pharmacoeconomic Benefits of Antihypertensive Therapy
por: Gonzalez, Edgar R.
Publicado: (2007) -
Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)